Michael E. Webb

Find an error

Name:
Organization: University of Leeds , England
Department: Astbury Centre for Structural Molecular Biology
Title: Associate Professor(PhD)
Co-reporter:A. Ivona Petrache, Darren C. Machin, Daniel J. Williamson, Michael E. Webb and Paul A. Beales  
Molecular BioSystems 2016 vol. 12(Issue 6) pp:1760-1763
Publication Date(Web):06 Apr 2016
DOI:10.1039/C6MB00126B
Lipid nanodiscs have broad applications in membrane protein assays, biotechnology and materials science. Chemical modification of the nanodiscs to expand their functional attributes is generally desirable for all of these uses. We present a method for site-selective labelling of the N-terminus of the nanodisc's membrane scaffold protein (MSP) using the Sortase A protein. Labelling of the MSP was achieved when assembled within the lipid nanodisc architecture, demonstrating that this method can be used as a retrofit approach to modification of preformed nanodiscs before or during application. We label the MSP with a fluorescent fluorescein moiety and use them to image nanodisc uptake into HeLa cells. The Sortase A labelling method could be employed as a general approach to labelling nanodiscs with application-specific functionalities.
Co-reporter:Philip M. Morrison;Matthew R. Balmforth;Samuel W. Ness;Dr. Daniel J. Williamson;Dr. Michael D. Rugen;Dr. W. Bruce Turnbull;Dr. Michael E. Webb
ChemBioChem 2016 Volume 17( Issue 8) pp:753-758
Publication Date(Web):
DOI:10.1002/cbic.201500547

Abstract

High-throughput studies have been widely used to identify protein–protein interactions; however, few of these candidate interactions have been confirmed in vitro. We have used a combination of isothermal titration calorimetry and fluorescence anisotropy to screen candidate interactions within the pantothenate biosynthetic pathway. In particular, we observed no interaction between the next enzyme in the pathway, pantothenate synthetase (PS), and aspartate decarboxylase, but did observe an interaction between PS and the putative Nudix hydrolase, YfcD. Confirmation of the interaction by fluorescence anisotropy was dependent upon labelling an adventitiously formed glycine on the protein N-terminal affinity purification tag by using Sortase. Subsequent formation of the protein–protein complex led to apparent restriction of the dynamics of this tag, thus suggesting that this approach could be generally applied to a subset of other protein–protein interaction complexes.

Co-reporter:Philip M. Morrison, Patrick J. Foley, Stuart L. Warriner and Michael E. Webb  
Chemical Communications 2015 vol. 51(Issue 70) pp:13470-13473
Publication Date(Web):23 Jul 2015
DOI:10.1039/C5CC05469A
Chemical formation of dehydroalanine has been widely used for the post-translational modification of proteins and peptides, however methods to incorporate multiple dehydroalanine residues into a single peptide have not been defined. We report the use of methyl 2,5-dibromovalerate which can be used to cleanly carry out this transformation.
Co-reporter:Diana C.F. Monteiro, Vijay Patel, Christopher P. Bartlett, Shingo Nozaki, Thomas D. Grant, James A. Gowdy, Gary S. Thompson, Arnout P. Kalverda, Edward H. Snell, Hironori Niki, Arwen R. Pearson, Michael E. Webb
Chemistry & Biology 2015 Volume 22(Issue 4) pp:492-503
Publication Date(Web):23 April 2015
DOI:10.1016/j.chembiol.2015.03.017
•Structure of the PanD-PanZ.AcCoA complex is reported at a resolution of 1.6 Å•Binding of AcCoA to PanZ is required to form the PanZ/PanD interface•PanZ.AcCoA activates PanD via selection of a reactive conformation of PanD•PanZ.AcCoA inhibits the activated enzyme, regulating pantothenate biosynthesisCoenzyme A (CoA) is an ubiquitous and essential cofactor, synthesized from the precursor pantothenate. Vitamin biosynthetic pathways are normally tightly regulated, including the pathway from pantothenate to CoA. However, no regulation of pantothenate biosynthesis has been identified. We have recently described an additional component in the pantothenate biosynthetic pathway, PanZ, which promotes the activation of the zymogen, PanD, to form aspartate α-decarboxylase (ADC) in a CoA-dependent manner. Here we report the structure of PanZ in complex with PanD, which reveals the structural basis for the CoA dependence of this interaction and activation. In addition, we show that PanZ acts as a CoA-dependent inhibitor of ADC catalysis. This inhibitory effect can effectively regulate the biosynthetic pathway to pantothenate, and thereby also regulate CoA biosynthesis. This represents a previously unobserved mode of metabolic regulation whereby a cofactor-utilizing protein negatively regulates the biosynthesis of the same cofactor.Figure optionsDownload full-size imageDownload high-quality image (187 K)Download as PowerPoint slide
Co-reporter:Katherine A. Horner;Dr. Nathalie M. Valette ;Dr. Michael E. Webb
Chemistry - A European Journal 2015 Volume 21( Issue 41) pp:14376-14381
Publication Date(Web):
DOI:10.1002/chem.201502397

Abstract

Strain-promoted inverse electron-demand Diels–Alder cycloaddition (SPIEDAC) reactions between 1,2,4,5-tetrazines and strained dienophiles, such as bicyclononynes, are among the fastest bioorthogonal reactions. However, the synthesis of 1,2,4,5-tetrazines is complex and can involve volatile reagents. 1,2,4-Triazines also undergo cycloaddition reactions with acyclic and unstrained dienophiles at elevated temperatures, but their reaction with strained alkynes has not been described. We postulated that 1,2,4-triazines would react with strained alkynes at low temperatures and therefore provide an alternative to the tetrazine cycloaddition reaction for use in in vitro or in vivo labelling experiments. We describe the synthesis of a 1,2,4-triazin-3-ylalanine derivative fully compatible with the fluorenylmethyloxycarbonyl (Fmoc) strategy for peptide synthesis and demonstrate its reaction with strained bicyclononynes at 37 °C with rates comparable to the reaction of azides with the same substrates. The synthetic route to triazinylalanine is readily adaptable to late-stage functionalization of other probe molecules, and the 1,2,4-triazine-SPIEDAC therefore has potential as an alternative to tetrazine cycloaddition for applications in cellular and biochemical studies.

Co-reporter:Katherine A. Horner;Dr. Nathalie M. Valette ;Dr. Michael E. Webb
Chemistry - A European Journal 2015 Volume 21( Issue 41) pp:
Publication Date(Web):
DOI:10.1002/chem.201584103
Co-reporter:Dr. Tom E. McAllister;Katherine A. Horner ;Dr. Michael E. Webb
ChemBioChem 2014 Volume 15( Issue 8) pp:1088-1091
Publication Date(Web):
DOI:10.1002/cbic.201402090

Abstract

We have investigated the interaction of peptides containing phosphohistidine analogues and their homologues with the prototypical phosphotyrosine binding SH2 domain from the eukaryotic cell signalling protein Grb2 by using a combination of isothermal titration calorimetry and a fluorescence anisotropy competition assay. These investigations demonstrated that the triazole class of phosphohistidine analogues are capable of binding too, suggesting that phosphohistidine could potentially be detected by this class of proteins in vivo.

Co-reporter:Tom E. M c Allister and Michael E. Webb  
Organic & Biomolecular Chemistry 2012 vol. 10(Issue 20) pp:4043-4049
Publication Date(Web):20 Mar 2012
DOI:10.1039/C2OB25517K
Phosphorylation of histidine is essential for bacterial two-component signalling; its importance to modulation of eukaryotic protein function remains undefined. Until recently, no immunochemical probes of this post-translational modification existed, however triazole phosphonate analogues of this modified amino acid have now been applied to the generation of site-specific antibodies. The protecting group strategy used in the original report is incompatible with standard protocols for Fmoc-solid phase peptide synthesis. In this paper, we report the application of P(III) chemistry to generate the complementary dibenzyl and di-tert-butyl phosphonate esters. These forms of the triazole analogue are fully compatible with standard Fmoc-SPPS and are therefore ideal for wider application by the chemical and biochemical community.
Co-reporter:Daniel J. Williamson;Dr. Martin A. Fascione;Dr. Michael E. Webb;Dr. W. Bruce Turnbull
Angewandte Chemie International Edition 2012 Volume 51( Issue 37) pp:9377-9380
Publication Date(Web):
DOI:10.1002/anie.201204538
Co-reporter:Daniel J. Williamson;Dr. Martin A. Fascione;Dr. Michael E. Webb;Dr. W. Bruce Turnbull
Angewandte Chemie 2012 Volume 124( Issue 37) pp:9511-9514
Publication Date(Web):
DOI:10.1002/ange.201204538
Co-reporter:Tom E. McAllister, Michael G. Nix and Michael E. Webb  
Chemical Communications 2011 vol. 47(Issue 4) pp:1297-1299
Publication Date(Web):22 Nov 2010
DOI:10.1039/C0CC04238B
We report the synthesis of the phosphohistidine analogue, Fmoc-4-diethylphosphonotriazolylalanine 5 and its incorporation into peptides. Our synthesis of 5 has enabled us to demonstrate that the analogue is compatible with Fmoc-solid phase peptide synthesis (SPPS) conditions. Standard cleavage conditions yield the diethyl phosphonate-protected peptide, however this can be subsequently deprotected using trimethylsilyl bromide to yield the free phosphonic acid-containing peptides.
Co-reporter:Tom E. McAllister, Michael G. Nix and Michael E. Webb
Chemical Communications 2011 - vol. 47(Issue 4) pp:NaN1299-1299
Publication Date(Web):2010/11/22
DOI:10.1039/C0CC04238B
We report the synthesis of the phosphohistidine analogue, Fmoc-4-diethylphosphonotriazolylalanine 5 and its incorporation into peptides. Our synthesis of 5 has enabled us to demonstrate that the analogue is compatible with Fmoc-solid phase peptide synthesis (SPPS) conditions. Standard cleavage conditions yield the diethyl phosphonate-protected peptide, however this can be subsequently deprotected using trimethylsilyl bromide to yield the free phosphonic acid-containing peptides.
Co-reporter:Tom E. M c Allister and Michael E. Webb
Organic & Biomolecular Chemistry 2012 - vol. 10(Issue 20) pp:NaN4049-4049
Publication Date(Web):2012/03/20
DOI:10.1039/C2OB25517K
Phosphorylation of histidine is essential for bacterial two-component signalling; its importance to modulation of eukaryotic protein function remains undefined. Until recently, no immunochemical probes of this post-translational modification existed, however triazole phosphonate analogues of this modified amino acid have now been applied to the generation of site-specific antibodies. The protecting group strategy used in the original report is incompatible with standard protocols for Fmoc-solid phase peptide synthesis. In this paper, we report the application of P(III) chemistry to generate the complementary dibenzyl and di-tert-butyl phosphonate esters. These forms of the triazole analogue are fully compatible with standard Fmoc-SPPS and are therefore ideal for wider application by the chemical and biochemical community.
Co-reporter:Philip M. Morrison, Patrick J. Foley, Stuart L. Warriner and Michael E. Webb
Chemical Communications 2015 - vol. 51(Issue 70) pp:NaN13473-13473
Publication Date(Web):2015/07/23
DOI:10.1039/C5CC05469A
Chemical formation of dehydroalanine has been widely used for the post-translational modification of proteins and peptides, however methods to incorporate multiple dehydroalanine residues into a single peptide have not been defined. We report the use of methyl 2,5-dibromovalerate which can be used to cleanly carry out this transformation.
PHOSPHOHISTIDINE
6-phenyl-1,2,4-triazin-3-amine
L-Serine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, methyl ester,4-methylbenzenesulfonate (ester)
EC 1.1.3.4
L-Histidine, L-histidyl-L-histidyl-L-histidyl-L-histidyl-L-histidyl-
Histidine, phosphono-
L-Alanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-iodo-, methyl ester
L-Histidine, 1-phosphono-
STRONTIUM;OCTADECANOATE
(R)-2-VINYL-OXIRANE